Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003502890 | SCV004253574 | pathogenic | Biotin-responsive basal ganglia disease | 2023-11-20 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn297Phefs*21) in the SLC19A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC19A3 are known to be pathogenic (PMID: 23423671, 23482991). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC19A3-related conditions. For these reasons, this variant has been classified as Pathogenic. |